MedTrace Logo

Erythropoietin Therapy for Children With Cerebral Palsy

NCT01650415 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2017-10-12

No results posted yet for this study

Summary

This randomized placebo-controlled trial aims to investigate the efficacy and safety of erythropoetin for children with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

DRUG

Erythropoietin

twice a week for 1 month

DRUG

Placebo erythropoietin

twice a week for 1 month

Sponsors & Collaborators

  • LG Life Sciences

    collaborator INDUSTRY

  • Bundang CHA Hospital

    lead OTHER

Principal Investigators

  • Minyoung Kim, M.D., Ph.D. · CHA University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-02-28
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01650415 on ClinicalTrials.gov